Literature DB >> 3044461

Graft versus leukemia in bone marrow transplantation.

M Boranić1.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3044461     DOI： 10.1007/BF00319727

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  103 in total

Review 1.  Bone-marrow transplantation (first of two parts).

Authors:  E Thomas; R Storb; R A Clift; A Fefer; F L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-17       Impact factor: 91.245

2.  Immunobiology of the graft-versus-host reaction. II. The role of proliferation in the development of specific antihost immune responsiveness.

Authors:  E A Wolters; R Benner
Journal:  Transplantation       Date:  1979-01       Impact factor: 4.939

3.  Blood and neoplastic diseases. Acute lymphoblastic leukaemia.

Authors:  M L Willoughby
Journal:  Br Med J       Date:  1974-11-02

4.  Transient graft-versus-host reaction in the treatment of leukemia in mice.

Authors:  M Boranić
Journal:  J Natl Cancer Inst       Date:  1968-08       Impact factor: 13.506

5.  The influence of the microbial flora on incidence of graft-versus-host disease in human allogeneic bone marrow transplantation.

Authors:  T Schmeiser; E Kurrle; R Arnold; W Heit; D Krieger; B Kubanek; H Heimpel
Journal:  Prog Clin Biol Res       Date:  1985

6.  Lymphocyte dysfunction in chronic graft-versus-host disease.

Authors:  A Saxon; R E McIntyre; R H Stevens; R P Gale
Journal:  Blood       Date:  1981-10       Impact factor: 22.113

7.  Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.

Authors:  P L Weiden; N Flournoy; E D Thomas; R Prentice; A Fefer; C D Buckner; R Storb
Journal:  N Engl J Med       Date:  1979-05-10       Impact factor: 91.245

8.  Manipulation of graft-versus-host disease for a graft-versus-leukemia effect after allogeneic bone marrow transplantation in AKR mice with spontaneous leukemia/lymphoma.

Authors:  R L Truitt; C C Shih; A V LeFever
Journal:  Transplantation       Date:  1986-03       Impact factor: 4.939

9.  High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot study.

Authors:  S N Wolff; J Marion; R S Stein; J M Flexner; H M Lazarus; T R Spitzer; G L Phillips; R H Herzig; G P Herzig
Journal:  Blood       Date:  1985-06       Impact factor: 22.113

10.  Graft versus host disease-related secretory immunoglobulin A deficiency in bone marrow transplant recipients. Findings in labial saliva.

Authors:  K T Izutsu; T W Menard; M M Schubert; W Y Ensign; K Sullivan; E L Truelove; E D Thomas
Journal:  Lab Invest       Date:  1985-03       Impact factor: 5.662
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.